• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制 p53 和 ATRX 可增加原代成纤维细胞中端粒的重组。

Inhibition of p53 and ATRX increases telomeric recombination in primary fibroblasts.

机构信息

Dipartimento di Scienze, Università "Roma Tre", Italy.

出版信息

FEBS Open Bio. 2023 Sep;13(9):1683-1698. doi: 10.1002/2211-5463.13680. Epub 2023 Aug 3.

DOI:10.1002/2211-5463.13680
PMID:37499040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10476563/
Abstract

Telomere length can be maintained either by the telomerase enzyme or by alternative lengthening of telomeres (ALT), which is based on telomeric recombination. However, both mechanisms are inactive in most human somatic cells. ATRX has been previously identified as an ALT repressor gene. Nonetheless, TP53 is also deficient in most ALT cell lines, and previous works showed that it is an inhibitor of homologous recombination (HR). Despite this, the role of p53 as an ALT repressor has not been previously examined. Therefore, we investigated the effects of p53 and ATRX inhibition on normal human fibroblasts (devoid of any mutation), in the presence or absence of X-ray-induced telomeric damage. Performing immunofluorescence with antibodies for RAD51, H2AX, and TRF1 (for studying HR-mediated DNA damage repair) and CO-FISH (for telomeric sister chromatid exchanges), we observed that HR is a normal mechanism for the repair of telomeric damage, present also in noncancer cells. Moreover, we discovered that telomeric HR, as for HR in general, is significantly inhibited by p53. Indeed, we observed that inhibition of p53 drastically increases telomeric sister chromatid exchanges. We also confirmed that ATRX inhibition increases telomeric recombination. In particular, we observed an increase in crossover products, but a much higher increase in noncrossover products.

摘要

端粒长度可以通过端粒酶或端粒的非经典延长(ALT)来维持,后者基于端粒重组。然而,这两种机制在大多数人类体细胞中都不活跃。ATRX 先前被鉴定为 ALT 抑制基因。尽管如此,TP53 在大多数 ALT 细胞系中也缺失,并且先前的研究表明它是同源重组(HR)的抑制剂。尽管如此,p53 作为 ALT 抑制剂的作用尚未得到先前的研究。因此,我们研究了在存在或不存在 X 射线诱导的端粒损伤的情况下,p53 和 ATRX 抑制对正常人类成纤维细胞(没有任何突变)的影响。通过用 RAD51、H2AX 和 TRF1(用于研究 HR 介导的 DNA 损伤修复)和 CO-FISH(用于端粒姐妹染色单体交换)的抗体进行免疫荧光,我们观察到 HR 是修复端粒损伤的正常机制,在非癌细胞中也存在。此外,我们发现端粒 HR 与一般的 HR 一样,被 p53 显著抑制。事实上,我们观察到 p53 的抑制会大大增加端粒姐妹染色单体交换。我们还证实 ATRX 抑制会增加端粒重组。特别是,我们观察到交叉产物增加,但非交叉产物增加更多。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0a/10476563/22f937863222/FEB4-13-1683-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0a/10476563/838f34fec477/FEB4-13-1683-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0a/10476563/751ba3d08d12/FEB4-13-1683-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0a/10476563/456e5fc889bb/FEB4-13-1683-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0a/10476563/8573f9d55d1d/FEB4-13-1683-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0a/10476563/22f937863222/FEB4-13-1683-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0a/10476563/838f34fec477/FEB4-13-1683-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0a/10476563/751ba3d08d12/FEB4-13-1683-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0a/10476563/456e5fc889bb/FEB4-13-1683-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0a/10476563/8573f9d55d1d/FEB4-13-1683-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea0a/10476563/22f937863222/FEB4-13-1683-g006.jpg

相似文献

1
Inhibition of p53 and ATRX increases telomeric recombination in primary fibroblasts.抑制 p53 和 ATRX 可增加原代成纤维细胞中端粒的重组。
FEBS Open Bio. 2023 Sep;13(9):1683-1698. doi: 10.1002/2211-5463.13680. Epub 2023 Aug 3.
2
Effects of p53 and ATRX inhibition on telomeric recombination in aging fibroblasts.p53和ATRX抑制对衰老成纤维细胞端粒重组的影响。
Front Oncol. 2024 Jan 25;14:1322438. doi: 10.3389/fonc.2024.1322438. eCollection 2024.
3
Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT).携带 ATRX 和/或 DAXX 突变的结直肠癌患者来源的类器官和细胞系缺乏端粒的非经典延长(ALT)。
Cell Death Dis. 2023 Feb 9;14(2):96. doi: 10.1038/s41419-023-05640-3.
4
Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma.突变 IDH1 与 ATRX 缺失协同作用驱动胶质瘤端粒的替代性延长表型。
Cancer Res. 2018 Jun 1;78(11):2966-2977. doi: 10.1158/0008-5472.CAN-17-2269. Epub 2018 Mar 15.
5
ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity.ATR-X 蛋白通过促进着丝粒黏合和依赖于 DAXX 的活性来影响端粒 DSB 的修复。
PLoS Biol. 2020 Jan 2;18(1):e3000594. doi: 10.1371/journal.pbio.3000594. eCollection 2020 Jan.
6
The macroH2A1.2 histone variant links ATRX loss to alternative telomere lengthening.组蛋白变体 macroH2A1.2 将 ATRX 缺失与替代性端粒延长联系起来。
Nat Struct Mol Biol. 2019 Mar;26(3):213-219. doi: 10.1038/s41594-019-0192-3. Epub 2019 Mar 4.
7
ATRX/DAXX: Guarding the Genome against the Hazards of ALT.ATR/DAXX:保护基因组免受 ALT 危害。
Genes (Basel). 2023 Mar 24;14(4):790. doi: 10.3390/genes14040790.
8
ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner.ATRX 缺失以细胞系特异性的方式诱导人神经胶质瘤细胞系中端粒延长的替代性延长(ALT)表型的多种特征。
PLoS One. 2018 Sep 18;13(9):e0204159. doi: 10.1371/journal.pone.0204159. eCollection 2018.
9
Functional Loss of and Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.在 LAPC4 前列腺癌细胞中, 和 的功能丧失会激活端粒的替代性延长(ALT)。
Mol Cancer Res. 2019 Dec;17(12):2480-2491. doi: 10.1158/1541-7786.MCR-19-0654. Epub 2019 Oct 14.
10
Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin.端粒的替代性延长的特点是端粒染色质的压缩减少。
Nucleic Acids Res. 2014 Apr;42(7):4391-405. doi: 10.1093/nar/gku114. Epub 2014 Feb 5.

引用本文的文献

1
Alternative Lengthening of Telomeres: The Need for Mutations Is Lineage-Dependent.端粒的替代延长:对突变的需求因谱系而异。
Int J Mol Sci. 2025 Jul 15;26(14):6765. doi: 10.3390/ijms26146765.
2
Effects of p53 and ATRX inhibition on telomeric recombination in aging fibroblasts.p53和ATRX抑制对衰老成纤维细胞端粒重组的影响。
Front Oncol. 2024 Jan 25;14:1322438. doi: 10.3389/fonc.2024.1322438. eCollection 2024.

本文引用的文献

1
TERT Extra-Telomeric Roles: Antioxidant Activity and Mitochondrial Protection.TERT 端粒外作用:抗氧化活性和线粒体保护。
Int J Mol Sci. 2023 Feb 23;24(5):4450. doi: 10.3390/ijms24054450.
2
A non-genetic switch triggers alternative telomere lengthening and cellular immortalization in ATRX deficient cells.非遗传开关触发 ATRX 缺陷细胞中替代性端粒延长和细胞永生化。
Nat Commun. 2023 Feb 20;14(1):939. doi: 10.1038/s41467-023-36294-6.
3
DAXX-ATRX regulation of p53 chromatin binding and DNA damage response.DAXX-ATRX 对 p53 染色质结合和 DNA 损伤反应的调控。
Nat Commun. 2022 Aug 26;13(1):5033. doi: 10.1038/s41467-022-32680-8.
4
Anti-recombination function of MutSα restricts telomere extension by ALT-associated homology-directed repair.MutSα 的抗重组功能通过 ALT 相关同源定向修复限制端粒延伸。
Cell Rep. 2021 Dec 7;37(10):110088. doi: 10.1016/j.celrep.2021.110088.
5
ATRX proximal protein associations boast roles beyond histone deposition.ATR-X 近端蛋白关联具有超出组蛋白沉积的作用。
PLoS Genet. 2021 Nov 15;17(11):e1009909. doi: 10.1371/journal.pgen.1009909. eCollection 2021 Nov.
6
Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma.p53缺失可抑制ATRX缺陷型神经母细胞瘤中复制应激诱导的DNA损伤。
Oncogenesis. 2021 Nov 6;10(11):73. doi: 10.1038/s41389-021-00363-6.
7
TERRA transcription destabilizes telomere integrity to initiate break-induced replication in human ALT cells.TERRA 转录物使端粒完整性不稳定,从而在人类 ALT 细胞中引发断裂诱导复制。
Nat Commun. 2021 Jun 18;12(1):3760. doi: 10.1038/s41467-021-24097-6.
8
ATRX and RECQ5 define distinct homologous recombination subpathways.ATR 和 RECQ5 定义了不同的同源重组亚途径。
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3). doi: 10.1073/pnas.2010370118.
9
Pifithrin-α alters p53 post-translational modifications pattern and differentially inhibits p53 target genes.Pifithrin-α 改变了 p53 的翻译后修饰模式,并差异抑制了 p53 的靶基因。
Sci Rep. 2020 Jan 23;10(1):1049. doi: 10.1038/s41598-020-58051-1.
10
Alternative Lengthening of Telomeres and Chromatin Status.端粒和染色质状态的替代性延长。
Genes (Basel). 2019 Dec 30;11(1):45. doi: 10.3390/genes11010045.